Tyreasea Anicha Johnson-Mason, NP

Tyreasea Johnson-Mason practices at Springfield Hospital in Springfield, Pennsylvania.

Tyreasea Johnson-Mason's NPI, 1003250101, was assigned on April 19, 2013. Tyreasea Johnson-Mason holds New Jersey license 26NJ00429100.

Tyreasea Johnson-Mason's primary practice is Springfield Hospital, at 190 W Sproul Rd, Springfield, PA 19064 in Delaware County. The practice phone is (610) 328-8700.

Tyreasea Johnson-Mason's primary practice is Springfield Hospital in Springfield, Pennsylvania. Dmand AI also links Tyreasea Johnson-Mason to 3 physician offices, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tyreasea Johnson-Mason practices, 4 sites in all. Vendor and product names are available with a free account.

Psychiatric/mental health is Tyreasea Johnson-Mason's primary specialty in the NPI Registry, under taxonomy code 363LP0808X. Dmand AI has Tyreasea Johnson-Mason's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS counts 40 Medicare patients who saw Tyreasea Johnson-Mason in 2026. The largest group is under 65, with 22 patients. 75% of them have anxiety, and 75% have mood disorders. 35% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Tyreasea Johnson-Mason's median patient age at 47, with 76% women.

In 2026, Tyreasea Johnson-Mason wrote 1,558 Medicare Part D claims for 81 patients. 93% of them were for generic drugs.

Tyreasea Johnson-Mason accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Tyreasea Johnson-Mason as offering telehealth.

CMS Open Payments shows 6 general payments to Tyreasea Johnson-Mason from 3 drug and device companies in 2025. Speaker and faculty fees make up the largest share, 62% of the total. Abbvie Inc. paid the most, $1,796.